In this edition of The Motley Fool's health care show, Market Checkup, analysts David Williamson and Max Macaluso take a close look at two of the most prominent potential turnaround stories in the pharmaceutical space: generic drugmaker Teva and struggling giant AstraZeneca.
David Williamson has no position in any stocks mentioned. Max Macaluso, Ph.D. has no position in any stocks mentioned. The Motley Fool recommends Johnson & Johnson. The Motley Fool owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.